Brief: Spyglass Pharma Announces Pricing Of IPO At $16.00 Per Share
06/02/2026 24:02
Feb 5 (Reuters) - SpyGlass Pharma Inc SGP.O: SPYGLASS PHARMA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING SPYGLASS PHARMA INC - PRICES IPO AT $16.00 PER SHARE SPYGLASS PHARMA INC - UNDERWRITERS GRANTED OPTION TO BUY 1,406,250 ADDITIONAL SHARES SPYGLASS PHARMA INC - EXPECTS $150 MILLION GROSS PROCEEDS FROM IPO Source text: ID:nGNX4R7T2b Further company coverage: SGP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on SpyGlass Pharma
See all newsBrief: Spyglass Pharma Announces Positive 4-Year Data From First-In-Human Trial Of BIM-Iol System
SpyGlass Pharma Q2 net loss widens on higher expenses
Brief: Spyglass Pharma Inc - BIM-Iol System Phase 3 Trial Enrollment Expected To Complete In 2027
Flagship-backed Generate Biomedicines eyes $2.2 billion valuation in US IPO (updated)
NASDAQ RESUMED AT 01:46 PM